Twitter Logo Youtube Circle Icon LinkedIn Icon

The Legal 500 Hall of Fame Icon The Legal 500 Hall of Fame highlights individuals who have received constant praise by their clients for continued excellence. The Hall of Fame highlights, to clients, the law firm partners who are at the pinnacle of the profession. In Europe, Middle East and Africa, the criteria for entry is to have been recognised by The Legal 500 as one of the elite leading lawyers for seven consecutive years. These partners are highlighted below and throughout the editorial.
Click here for more details

Switzerland > Legal Developments > Law firm and leading lawyer rankings

Editorial

Bär & Karrer Advised UBS and Mirabaud on the Placement of Shares of Santhera Pharmaceuticals Holdin

January 2019 - Corporate & Commercial. Legal Developments by BÄR & KARRER LTD..

More articles by this firm.

Santhera Pharmaceuticals Holding AG (Santhera) placed 3,133,334 new shares at an offer price of CHF 7.50 per share. The shares were placed by way of an accelerated bookbuilding procedure in a public offering in Switzerland, in private placements outside of the United States and Switzerland and in private placements within the United States to qualified institutional buyers. The shares were issued under exclusion of the existing shareholders' subscription rights through an ordinary capital increase resolved by an extraordinary shareholders' meeting.

The gross proceeds from the placement amounted to CHF 23.5 million. Santhera intends to use the proceeds primarily to pay the cash component of the consideration to Idorsia Ltd for the acquisition of the option for the exclusive sub-license of vamorolone, a drug candidate for the treatment of patients with Duchenne muscular dystrophy.

Bär & Karrer acted as Swiss legal advisor to UBS AG (Global Coordinator and Bookrunner) and Mirabaud Securities Limited (Co-Manager). The team included Thomas U. Reutter, Daniel Raun, Annette Weber and Anna Capaul (all Capital Markets) as well as Christoph Suter (Tax).

Santhera Pharmaceuticals Holding AG (Santhera) placed 3,133,334 new shares at an offer price of CHF 7.50 per share. The shares were placed by way of an accelerated bookbuilding procedure in a public offering in Switzerland, in private placements outside of the United States and Switzerland and in private placements within the United States to qualified institutional buyers. The shares were issued under exclusion of the existing shareholders' subscription rights through an ordinary capital increase resolved by an extraordinary shareholders' meeting.

The gross proceeds from the placement amounted to CHF 23.5 million. Santhera intends to use the proceeds primarily to pay the cash component of the consideration to Idorsia Ltd for the acquisition of the option for the exclusive sub-license of vamorolone, a drug candidate for the treatment of patients with Duchenne muscular dystrophy.

Bär & Karrer acted as Swiss legal advisor to UBS AG (Global Coordinator and Bookrunner) and Mirabaud Securities Limited (Co-Manager). The team included Thomas U. Reutter, Daniel Raun, Annette Weber and Anna Capaul (all Capital Markets) as well as Christoph Suter (Tax).

Interview with...

Law firm partners and practice heads explain how their firms are adapting to clients' changing needs

International Law Firm Networks

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

GC Powerlist -
Europe

International Law Firm Networks